Kohlberg Kravis Roberts & Co. L.P. - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 26 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Kohlberg Kravis Roberts & Co. L.P. ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$13,509,377
+4.9%
13,507,000
+3.8%
0.41%
-6.4%
Q4 2022$12,877,281
+318.6%
13,007,000
+311.2%
0.44%
+601.6%
Q3 2022$3,076,000
+0.3%
3,163,0000.0%0.06%
+51.2%
Q2 2022$3,068,000
+0.6%
3,163,000
-4.7%
0.04%
+46.4%
Q1 2022$3,050,000
-3.0%
3,320,0000.0%0.03%
+64.7%
Q4 2021$3,144,000
-94.6%
3,320,000
-94.9%
0.02%
-92.8%
Q2 2021$58,191,000
+40.3%
64,548,000
+28.8%
0.24%
+12.9%
Q1 2021$41,465,000
+199.4%
50,109,000
+186.3%
0.21%
+198.6%
Q4 2020$13,850,00017,500,0000.07%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 5,324,000$4,995,0003.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$53,020,0002.12%
DLD Asset Management, LP 32,500,000$30,048,0002.06%
Castle Creek Arbitrage, LLC 4,504,000$4,161,0001.43%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$9,372,0000.62%
Graham Capital Management, L.P. 14,636,000$13,509,0000.60%
OAKTREE CAPITAL MANAGEMENT LP 64,452,000$59,704,0000.54%
Context Capital Management, LLC 1,000,000$926,0000.52%
ADVENT CAPITAL MANAGEMENT /DE/ 23,118,000$21,341,0000.52%
WOLVERINE ASSET MANAGEMENT LLC 18,583,000$17,322,0000.21%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders